Enliven Therapeutics
ELVN
#3813
Rank
โ‚น347.33 B
Marketcap
โ‚น4,740
Share price
-1.57%
Change (1 day)
170.06%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of March 2026 : โ‚น28.95 Million

According to Enliven Therapeutics's latest financial reports the company's total debt is โ‚น28.95 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚น35.81 M
2024-12-31N/A-100%
2023-12-31โ‚น27.88 M4.34%
2022-12-31โ‚น26.72 M125.85%
2021-12-31โ‚น11.83 M54.11%
2020-12-31โ‚น7.67 M